Tiefenbacher Group has inaugurated its new development and production facilities in Hyderabad, India. The newly constructed complex covers 4,000 square meters and includes laboratories, administrative offices, and an oncology drug production unit. The company has also initiated the expansion of its existing Production Block 1, which is used for manufacturing pharmaceuticals for other indications.
According to the company, the new facility is designed to meet GxP compliance standards and houses product development and analytical laboratories. The oncology unit will support the company’s pipeline of over 20 highly potent oncology drugs.
The inauguration event was attended by the company’s managing directors, Tiefenbacher family shareholders, and advisory board members. The company stated that this investment will contribute to its pharmaceutical development and production capabilities.